Skip to main content
main-content

Pediatric rheumatology

Non-pharmacologic treatment

Enhancing clinical assessment with ultrasonography in juvenile idiopathic arthritis

Johannes Roth outlines the rationale behind the use of musculoskeletal ultrasonography in children with juvenile idiopathic arthritis, including enhancement of clinical assessment as part of a treat-to-target approach.

18-03-2019 | Juvenile idiopathic arthritis | Editorial | Article

Enhancing clinical assessment with ultrasonography in juvenile idiopathic arthritis

Johannes Roth outlines the rationale behind the use of musculoskeletal ultrasonography in children with juvenile idiopathic arthritis, including enhancement of clinical assessment as part of a treat-to-target approach.

Sustained smoking cessation may reduce excess RA risk

Maintaining a nonsmoking status for a sustained period is associated with a reduction in the excess risk for developing seropositive rheumatoid arthritis, findings suggest.

04-03-2019 | Rheumatoid arthritis | Highlight | News

Sustained smoking cessation may reduce excess RA risk

Maintaining a nonsmoking status for a sustained period is associated with a reduction in the excess risk for developing seropositive rheumatoid arthritis, findings suggest.

01-03-2019 | Osteoarthritis | News

Delayed exercise interventions offer unclear benefits after TKR

The benefits of later-stage exercise programs after total knee replacement are unclear, say researchers, who found a disconnect between patient-reported outcomes and performance-based tests.

01-03-2019 | Juvenile idiopathic arthritis | Editorial | Article

The microbiota in juvenile idiopathic arthritis: What’s wrong, and what can we do?

In this editorial, Matthew Stoll explores the role of the microbiota in the pathogenesis of juvenile idiopathic arthritis, as well as current research into therapeutic alterations of the microbiome.

The microbiota in juvenile idiopathic arthritis: What’s wrong, and what can we do?

In this editorial, Matthew Stoll explores the role of the microbiota in the pathogenesis of juvenile idiopathic arthritis, as well as current research into therapeutic alterations of the microbiome.

28-02-2019 | Juvenile idiopathic arthritis | News

Substantial proportion of patients with JIA have ongoing disease as adults

Almost half of patients with juvenile idiopathic arthritis have ongoing active disease during early adulthood, with the burden particularly high among those with enthesitis-related arthritis, researchers report.

26-02-2019 | Osteoarthritis | News

Pros and cons of knee replacement options reviewed

Patients undergoing unicompartmental knee arthroplasty have shorter hospital stays and fewer early complications than those receiving total knee arthroplasty but are more likely to need a revision within 5 years, results of a large meta-analysis show.

22-02-2019 | Adalimumab biosimilar | News

EMA gives nod to two adalimumab biosimilars

The Committee for Medicinal Products for Human Use has recommended two new adalimumab biosimilars for approval in Europe.

21-02-2019 | Osteoarthritis | News

Shoulder replacement surgery riskier than previously thought

Study findings published in The BMJ suggest that the risk for serious adverse events following shoulder replacement surgery is greater than previously considered, and the likelihood of requiring revision surgery is elevated in younger patients.

20-02-2019 | Osteoarthritis | News

Repeat intra-articular corticosteroid injections feasible for knee OA patients

Findings from an open-label phase IIIb trial suggest that repeat administration of extended-release triamcinolone acetonide is well tolerated and may result in symptomatic relief for patients with knee osteoarthritis.

18-02-2019 | Rheumatoid arthritis | News

No benefit of prolonged abatacept cessation before joint replacement in RA patients

Among patients with rheumatoid arthritis undergoing elective joint replacement, stopping intravenous abatacept treatment for more than one dosing interval prior to surgery may not result in better postoperative outcomes than a shorter length of discontinuation, researchers report.

Longevity of hip, knee replacements in OA patients estimated

Two meta-analyses published in The Lancet provide estimates for how long hip and knee replacements are likely to last in patients with osteoarthritis.

15-02-2019 | Osteoarthritis | Highlight | News

Longevity of hip, knee replacements in OA patients estimated

Two meta-analyses published in The Lancet provide estimates for how long hip and knee replacements are likely to last in patients with osteoarthritis.

Ibuprofen may be a ‘reasonable option’ for analgesia after hip replacement

Patients who are treated with ibuprofen alone experience comparable pain control in the first day after hip replacement to those give acetaminophen plus ibuprofen, findings from the PANSAID trial suggest.

12-02-2019 | Osteoarthritis | Highlight | News

Ibuprofen may be a ‘reasonable option’ for analgesia after hip replacement

Patients who are treated with ibuprofen alone experience comparable pain control in the first day after hip replacement to those give acetaminophen plus ibuprofen, findings from the PANSAID trial suggest.

Weight-loss diet beneficial for obese PsA patients

Targeting weight loss with a very-low-calorie diet may improve measures of disease activity among obese patients with psoriatic arthritis, researchers report.

24-01-2019 | Psoriatic arthritis | Highlight | News

Weight-loss diet beneficial for obese PsA patients

Targeting weight loss with a very-low-calorie diet may improve measures of disease activity among obese patients with psoriatic arthritis, researchers report.

11-01-2019 | Juvenile idiopathic arthritis | News

Predictors of outcomes identified in JIA-associated uveitis

Demographic factors, measures of disease activity, and the type of treatment used are associated with 2-year outcomes among patients with juvenile idiopathic arthritis-associated uveitis, according to findings from the ICON-JIA study.

image credits